Epitopea’s Post

Epitopea at the International Neoantigen Summit 2025 🧬 We’re excited to share that our Chief Medical Officer, Dr. Klaus Edvardsen, will be contributing to two key sessions at the upcoming Neoantigen Summit in Amsterdam 🇳🇱 🗓️ Tuesday, 24 June – Pre-Conference Workshop C at 2:30 PM
 🧠 Workshop: How Personalised Should Neoantigen-Targeted Cell Therapies & Cancer Vaccines Be?
 Klaus will join fellow expert Robbert Spaapen, Associate Director of AstraZeneca 🗓️ Wednesday, 25 June at 12:00 PM – Main Conference Day 1
 🎤 Panel Discussion: Validating Immunogenicity of Neoantigens & Establishing a Consensus on Selecting Optimal Targets
 Here, Klaus will be accompanied by fellow panelists: Jingwei Sun, Vice President of R&D, Grit Biotechnology Sarah Maguire, CSO of AilseBio Reagan Jarvis, CEO of Anocca Katka Franke, Senior Director Cancer Antigen Discovery & Validation, CureVac 💬 Moderated by Vanesa Bol, GSK We look forward to these important conversations shaping the future of novel antigen-targeting strategies in immuno-oncology, and to connecting with our peers and collaborators in the field. 🔗 Learn about our CryptoMapTM platform and our Cryptigen™ tumor-specific antigens here: https://lnkd.in/ekHRyBMs #NeoantigenSummit #CancerImmunotherapy #Biotech #ImmunoOncology #Neoantigens #Innovation #CancerResearch #Epitopea Hanson Wade